Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease

Abstract

Background Recent studies reporting the intricate crosstalk between cellular and molecular mediators and the lymphatic endothelium in the development of inflammatory bowel diseases (IBD) suggest altered inflammatory cell drainage and lymphatic vasculature, implicating the lymphatic system as a player in the occurrence, development, and recurrence of intestinal diseases. This article aims to review recent data on the modulatory functions of cellular and molecular components of the IBD microenvironment on the lymphatic system, particularly lymphangiogenesis. It serves as a promising therapeutic target for IBD management and treatment. The interaction with gut microbiota is also explored. Main text Evidence shows that cells of the innate and adaptive immune system and certain non-immune cells participate in the complex processes of inflammatory-induced lymphangiogenesis through the secretion of a wide spectrum of molecular factors, which vary greatly among the various cells. Lymphangiogenesis enhances lymphatic fluid drainage, hence reduced infiltration of immunomodulatory cells and associated-inflammatory cytokines. Interestingly, some of the cellular mediators, including mast cells, neutrophils, basophils, monocytes, and lymphatic endothelial cells (LECs), are a source of lymphangiogenic molecules, and a target as they express specific receptors for lymphangiogenic factors. Conclusion The effective target of lymphangiogenesis is expected to provide novel therapeutic interventions for intestinal inflammatory conditions, including IBD, through both immune and non-immune cells and based on cellular and molecular mechanisms of lymphangiogenesis that facilitate inflammation resolution.

Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer

“…However, it is questionable whether H89 has an anti-inflammatory function (prevention of chemically induced carcinogenesis) or a proinflammatory function (by inducing IFN-γ). In our case, H89 induced IFN-γ (a proinflammatory cytokine essentially secreted by TLs and NK cells) which can induce an antitumor effect, unlike proinflammatory cytokines released by, e.g., neutrophils or monocytes, involved in inflammatory bowel disease (IBD) (for review: 40 ). Our results also revealed that the involvement of an adaptive response of the antitumor effect of H89 may be related to its ability to reduce the expression of PD-L1 and CD80 on cancer cells.…”

Immature myeloid cells are indispensable for intestinal regeneration post irradiation injury

“…The conclusion that IMCs can promote lymphangiogenesis have wider implications than in just regeneration. Lymphangiogenesis has been shown to be involved the development of breast cancer, colon cancer metastasis, and inflammatory bowel disease (Nandi et al, 2017; Ocansey et al, 2021; Tacconi et al, 2015). Thus, given their role in promoting LEC activation and sprouting by producing PGE2, it may be worth investigating the role of IMCs in these other conditions.…”

Eplerenone ameliorates lung fibrosis in unilateral ureteral obstruction rats by inhibiting lymphangiogenesis

“…Lymphatic vessels contribute to human diseases such as cardiovascular disease (28), renal fibrosis (29), interstitial lung disease (30), cancer metastasis (31) and inflammatory bowel disease (32). The features of chronic inflammation include lymphangiogenesis and blood vessel remodeling (33).…”